Exemplar Genetics Rare Neurological Disease Model Cleared by FDA for Commercial Research Use

SIOUX CENTER, Iowa, April 16, 2018 /PRNewswire/ -- Exemplar Genetics, a wholly owned subsidiary of Intrexon Corporation( XON) committed to enabling the study of life-threatening human diseases, today announced the U.S. Food & Drug Administration (FDA) has exercised enforcement discretion in regard to the ExeGen ®ATM MiniSwine model clearing it for commercial use as a research model.

The ExeGen ®ATM MiniSwine is genetically engineered (GE) to model ataxia telangiectasia (AT), a rare, inherited, predominantly neurological human disease. Exemplar has previously received approval for its ExeGen ®LDLR MiniSwine model for use in cardiovascular disease research.